How adaptive clinical trials save medtech time and money

Adaptive clinical trials are not a new concept, but they are new to medical device technology. The practice of conducting adaptive clinical trials has the potential to save manufacturers time and money, as well as help them get to market quicker. FDA has released guidelines recommending that medical device companies use adaptive designs in clinical research. Vicki Anastasi, Global Head of Medical Device and Diagnostics Research at ICON plc, shares key insights into FDA’s guidelines as well as her experience with the process.